← Back to Search

Pharmacy-Delivered PrEP for HIV/AIDS

N/A
Recruiting
Led By Natalie Crawford, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Customers who purchase prescriptions or other items from the pharmacy
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 3
Awards & highlights

Study Summary

This trial will test a new way to give the HIV prevention drug PrEP to black men who have sex with men, in order to make it more accessible and reduce HIV incidence.

Who is the study for?
This trial is for English-speaking Black men who have sex with men (BMSM), living in high poverty, minority neighborhoods and are customers at the participating pharmacy. There are no specific exclusion criteria mentioned, so it appears open to all within this group.Check my eligibility
What is being tested?
The study is testing a new way to deliver HIV prevention medication, known as PrEP (Pre-exposure Prophylaxis), through pharmacies specifically tailored for BMSM. The goal is to see if this increases the use of PrEP and helps reduce HIV rates.See study design
What are the potential side effects?
While side effects aren't detailed here, common ones associated with PrEP include nausea, headache, stomach pain, and weight loss. Most are mild and tend to go away over time.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I buy prescriptions or other items from the pharmacy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 3
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 3 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of participants continuing PrEP

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pharmacy delivered PrEP InterventionExperimental Treatment1 Intervention
Customers of the study pharmacies who participate in the intervention to receive PrEP through the pharmacy.

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,634 Previous Clinical Trials
2,560,094 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,777 Previous Clinical Trials
2,674,322 Total Patients Enrolled
Natalie Crawford, PhDPrincipal InvestigatorEmory University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is this trial engaging the participation of patients?

"Affirmative. Data hosted on clinicaltrials.gov confirms that this medical research, which was first posted on May 19th 2022, is actively searching for individuals to take part in the trial. Approximately 20 participants need to be recruited from 1 centre."

Answered by AI

Are there any openings still available for this research project?

"Affirmative, the clinicaltrials.gov website states that this experiment is actively seeking participants. It was initially announced on May 19th 2022 and its most recent alteration occurred on July 19th of the same year. They are recruiting twenty people from a single site."

Answered by AI
~4 spots leftby Jun 2024